The company will not receive any of the proceeds from the sale of these shares of its common stock by the selling stockholder.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INKT:
- MiNK Reports Second Quarter 2024 Results and Business Update
- Mink Therapeutics, Inc. (INKT) Q2 Earnings Cheat Sheet
- MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report
- MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement
- MiNK Therapeutics regains compliance with nasdaq MVLS requirement